Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Targeting Cdc42 with the anticancer compound MBQ-167 inhibits cell polarity and growth in the budding yeast S. cerevisiae.
Small GTPases. 2020 Nov;11(6):430-440. doi: 10.1080/21541248.2018.1495008. Epub 2018 Jul 29.
Small GTPases. 2020.
PMID: 29969362
Free PMC article.
Rac inhibition as a novel therapeutic strategy for EGFR/HER2 targeted therapy resistant breast cancer.
Borrero-García LD, Del Mar Maldonado M, Medina-Velázquez J, Troche-Torres AL, Velazquez L, Grafals-Ruiz N, Dharmawardhane S.
Borrero-García LD, et al. Among authors: medina velazquez j.
BMC Cancer. 2021 Jun 1;21(1):652. doi: 10.1186/s12885-021-08366-7.
BMC Cancer. 2021.
PMID: 34074257
Free PMC article.
Item in Clipboard
Cite
Cite